Experimental Neurobiology is a prominent academic journal published by the Korean Society for Brain and Neural Science and the Korean Society for Neurodegenerative Disease, dedicated to advancing the field of neurobiology. With an ISSN of 1226-2560 and an E-ISSN of 2093-8144, this journal plays a pivotal role in disseminating innovative research findings from 2015 to 2024. The journal has established its relevance within the scientific community, achieving a Q3 ranking in Cellular and Molecular Neuroscience and a Q2 ranking in Neurology (Clinical) as of 2023. Researchers exploring the complexities of neurobiology will find a platform for their findings, as it currently holds a rank of #182 in clinical neurology and #73 in cellular and molecular neuroscience within the Scopus database. Although open access is not presently available, the journal remains committed to academic excellence and provides a critical resource for those engaged in the study of neurological diseases and mechanisms.

Neurosciences is a premier academic journal dedicated to the exploration of neurological and psychiatric disorders, fostering an innovative exchange of ideas and research findings in these critical fields. Published by the Riyadh Armed Forces Hospital in Saudi Arabia, this interdisciplinary journal has consistently contributed to the advancement of knowledge since its inception in 2002 and is set to continue through 2024. With an ISSN of 1319-6138 and E-ISSN of 1658-3183, it is recognized for its emphasis on clinically relevant research in neurology and psychiatry, boasting a 2023 classification in the Q3 tier of both categories. Neurosciences encourages submissions that offer novel insights into mental health and neurological conditions, positioning itself as a vital resource for researchers, healthcare professionals, and students alike. Despite being unlisted as an open-access journal, it remains a respected outlet for peer-reviewed content, with Scopus rankings that highlight its growing influence within the scientific community. This journal serves as an essential platform for disseminating significant research that addresses the intricacies of the human brain and behavior.

NEUROPHARMACOLOGY, published by PERGAMON-ELSEVIER SCIENCE LTD, is a prestigious journal in the field of neuroscience and pharmacology, with a distinguished history dating back to 1962. With an ISSN of 0028-3908 and an E-ISSN of 1873-7064, the journal serves as a dynamic platform for the latest research that explores the intricate relationships between pharmacological agents and neural processes. Positioned in the Q1 quartile in both Cellular and Molecular Neuroscience and Pharmacology, it is recognized for its significant impact in the scientific community, boasting Scopus rankings of #36 in Pharmacology and #16 in Cellular and Molecular Neuroscience, underscoring its excellence and relevance. Although not an open access publication, its contributions are pivotal for researchers, professionals, and students sought to understand the complexities of neuropharmacological interactions. The journal aims to disseminate groundbreaking research findings, reviews, and perspectives that expand the frontiers of knowledge in the fields, making it an essential resource for anyone involved in neuroscience and pharmacology research.

Fluids and Barriers of the CNS is a premier open-access journal published by BMC, dedicated to advancing the field of neuroscience by exploring the complexities of the fluid dynamics and barriers of the central nervous system. Since its inception in 2011, the journal has established itself as a vital resource for researchers, professionals, and students alike, providing a platform for innovative research and critical discussions in areas such as cellular and molecular neuroscience, developmental neuroscience, neurology, and miscellaneous medicine. With an impressive Q1 ranking across multiple categories in 2023, and strong performance metrics such as being ranked in the 93rd percentile in Developmental Neuroscience, this journal not only highlights cutting-edge research but also contributes to the ongoing dialogue surrounding neurophysiology and pathology. As an open-access journal based in London, United Kingdom, it ensures that high-quality research is accessible to a global audience, fostering collaboration and knowledge-sharing in the neuroscientific community.

BMC NEUROSCIENCE is a prominent open access journal dedicated to the dissemination of high-quality research within the dynamic and rapidly evolving field of neuroscience. Published by BMC, a well-respected leader in open access publishing, this journal facilitates the free exchange of knowledge since its inception in 2000. With the ISSN 1471-2202, BMC NEUROSCIENCE aims to address the diverse interests of the neuroscience community by covering a broad spectrum of topics, ranging from cellular and molecular neuroscience to general neurological studies, thus appealing to researchers, professionals, and students alike. Although it currently holds a Q4 ranking in Cellular and Molecular Neuroscience and a Q3 rank in miscellaneous Neuroscience categories, its commitment to advancing the understanding of brain function and disorders remains steadfast. The journal features a user-friendly Open Access model, ensuring that critical research findings are readily accessible to everyone, fostering collaboration and innovation in the field. As the journal continues to evolve towards its convergence years of 2024, it aspires to enhance its impact and global reach, making it a valuable resource for anyone interested in advancing neuroscience research.

MOLECULAR PSYCHIATRY, published by SpringerNature, is a premier peer-reviewed journal that has established itself as a leading platform for the dissemination of cutting-edge research in the fields of neuroscience, molecular biology, and psychiatry. With an impressive impact factor and a reputation for excellence, the journal is ranked Q1 in key categories, signifying its high academic quality and relevance. The journal’s scope spans groundbreaking studies and innovative therapeutic approaches that intersect at the molecular and cellular levels, providing invaluable insights into the biological underpinnings of psychiatric disorders. Since its inception in 1996, MOLECULAR PSYCHIATRY has evolved to support both established and emerging researchers, fostering a collaborative environment that enhances the understanding of mental health. It is committed to improving access to scientific knowledge, although it currently does not offer open access options. With its headquarters in London, the journal continues to play a pivotal role in enhancing the global dialogue on psychiatric and neurological advancements, making it an essential resource for academics and professionals dedicated to advancing mental health sciences.

Frontiers in Neuroscience, published by FRONTIERS MEDIA SA, is a premier open-access journal dedicated to advancing our understanding of the nervous system through innovative and rigorous research. Since its inception in 2007, this journal has become an influential platform for researchers, featuring a diverse range of topics across various subfields of neuroscience. With its current ranking in the second quartile (Q2) of the category "Neuroscience (miscellaneous)" and a commendable position of #40 out of 113 in general neuroscience according to Scopus, Frontiers in Neuroscience is recognized for its high-impact contributions. The journal promotes free access to scholarly work, ensuring that cutting-edge neuroscience studies reach a global audience and foster collaboration across disciplines. By bridging gaps in knowledge and facilitating the exchange of ideas, Frontiers in Neuroscience plays a pivotal role in addressing the complexities of the nervous system and its effects on behavior, cognition, and health.

Nature Reviews Neurology, published by NATURE PORTFOLIO, stands as a leading scholarly journal dedicated to the field of neurology and neuroscience. With an impressive impact factor and a prestigious Q1 categorization in both Cellular and Molecular Neuroscience and Clinical Neurology, this journal provides cutting-edge reviews and insights into the latest research developments, trends, and clinical practices. Based in the United Kingdom and accessible to a global audience, Nature Reviews Neurology aims to foster knowledge dissemination and interdisciplinary collaboration among researchers, healthcare professionals, and educators. With an influential Scopus ranking, it remains a pivotal resource for those seeking to deepen their understanding of neurological disorders and therapies while remaining at the forefront of academic discourse and innovation in the field.

Acta Neuropathologica Communications is a distinguished open-access journal published by BMC since 2013, focusing on the rapidly advancing fields of neurology, cellular and molecular neuroscience, and pathology. Located in the United Kingdom, this journal serves as a vital platform for researchers to disseminate significant findings that enhance our understanding of neurological disorders and their underlying mechanisms. With an impressive impact factor reflected in its Q1 ranking across multiple relevant categories, including Cellular and Molecular Neuroscience, Neurology (Clinical), and Pathology and Forensic Medicine, Acta Neuropathologica Communications stands out in the academic community for its rigorous peer-review process and commitment to high-quality research. The journal’s Scopus rankings highlight its global relevance, placing it in the top percentiles among leading research publications. Researchers, professionals, and students alike are encouraged to access and contribute to this essential resource, fostering a collaborative and informed approach to tackling the complexities of neuropathology and neuroscience.

BRAIN RESEARCH is a premier journal published by Elsevier, specializing in the intricate domains of neuroscience, developmental biology, and molecular biology. Established in 1966, this esteemed publication has become a cornerstone for researchers, professionals, and students dedicated to advancing our understanding of brain function and disorders. With an impressive impact factor and a consistent presence in the Q2 quartiles across key categories—such as Developmental Biology, Neurology, and Neuroscience—it stands out as an essential resource for disseminating innovative research and pioneering insights. The journal's scope encompasses both clinical and fundamental studies, fostering a multidisciplinary approach to the complexities of neural systems. Although it is not an open-access journal, BRAIN RESEARCH provides a vital platform for sharing progressive findings that can inspire future studies and contribute significantly to the evolutionary discourse in neuroscience. Based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, BRAIN RESEARCH continues to shape the landscape of neuroscience research, inviting submissions that explore the latest discoveries and therapeutic strategies.